Short-Squeeze Buzz Has Petros Pharmaceuticals Rocketing

 Petros Pharmaceuticals (NASDAQ:PTPI) stock took off in pre-market trading on Monday as short-squeeze talk on social media pushes shares higher

Several traders are discussing PTPI stock on Twitter (NYSE:TWTR) with some mentioning it as today’s short-squeeze target. That includes a few with decent-sized audiences that could help spread the word of a short squeeze.

With that comes heavy trading of PTPI stock as retail traders pile into the company’s shares. As of this writing, more than 14 million shares of the stock have changed hands. That’s more than double the company’s daily average trading volume of about 6.6 million shares.

Of course, that doesn’t mean traders are going to want to dive tight into PTPI stock. We know this short squeeze can’t last forever. When it ends, there’s a good chance that some investors will be left holding the bag.

That’s the danger that comes with investing in penny stocks like PTPI. Its low price of just over $2 per share makes it easy to manipulate. The company also only has a market capitalization of $27.484 million. These are both factors to keep an eye on when a stock starts to rise with no news behind it.

PTPI stock is up 69% as of early Monday morning but is down 52.3% since the start of the year.

https://investorplace.com/2021/11/ptpi-stock-the-short-squeeze-buzz-that-has-petros-pharmaceuticals-rocketing-today/